Review
Survival associated with recommended risk-reducing interventions for individuals with pathogenic variants in BRCA1/2
Gynecologic Oncology
The paper
The University of Texas MD Anderson Cancer Center
Gynecologic Oncology · 22 Sep 2026
Gynecologic Oncology
The University of Texas MD Anderson Cancer Center
Gynecologic Oncology · 22 Sep 2026
Journal of the National Cancer Institute · 4 Oct 2026
Journal of the National Cancer Institute · 2 Oct 2026

medRxiv · 4 Oct 2026
The Lancet Healthy Longevity · 4 Oct 2026